Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02714036
Recruitment Status : Completed
First Posted : March 21, 2016
Last Update Posted : July 21, 2020
Sponsor:
Collaborators:
Massachusetts General Hospital
South Shore Neurologic Associates
Information provided by (Responsible Party):
MediciNova

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2019
Actual Study Completion Date : June 30, 2020
Publications: